Michael Makanga

1.5k total citations
32 papers, 923 citations indexed

About

Michael Makanga is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael Makanga has authored 32 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Public Health, Environmental and Occupational Health, 7 papers in Economics and Econometrics and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael Makanga's work include Malaria Research and Control (12 papers), Mosquito-borne diseases and control (10 papers) and Global Health and Surgery (10 papers). Michael Makanga is often cited by papers focused on Malaria Research and Control (12 papers), Mosquito-borne diseases and control (10 papers) and Global Health and Surgery (10 papers). Michael Makanga collaborates with scholars based in United Kingdom, Kenya and United States. Michael Makanga's co-authors include Srivicha Krudsood, Catherine O. Falade, Patricia Palacios, Zul Premji, Christine-Elke Ortmann, Ambrose Talisuna, J. Gabrielle Breugelmans, Gilbert Kokwaro, David Ubben and Theonest K. Mutabingwa and has published in prestigious journals such as The Lancet, Nature Communications and PLoS ONE.

In The Last Decade

Michael Makanga

29 papers receiving 879 citations

Peers

Michael Makanga

PHEOH

CTM

PHARM

PARAS

John Bosco Rwakimari Uganda

Innocent Valéa Burkina Faso

Eva Christophel Philippines

Benjamin Abuaku Ghana

Krongthong Thimasarn Thailand

Philip Sasi Tanzania

Dysoley Lek Cambodia

George Adjei Ghana

Daniel Blessborn Thailand

Samlane Phompida Laos

John Bosco Rwakimari Uganda

Michael Makanga

858 ×1.3

PHEOH

161 ×1.1

CTM

99 ×0.7

PHARM

113 ×0.9

158 ×1.4

PARAS

Citations per year, relative to Michael Makanga Michael Makanga (= 1×) peers John Bosco Rwakimari

Countries citing papers authored by Michael Makanga

Since Specialization

Citations

This map shows the geographic impact of Michael Makanga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Makanga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Makanga more than expected).

Fields of papers citing papers by Michael Makanga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Makanga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Makanga. The network helps show where Michael Makanga may publish in the future.

Co-authorship network of co-authors of Michael Makanga

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Makanga. A scholar is included among the top collaborators of Michael Makanga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Makanga. Michael Makanga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moorthy, Vasee, Nandi Siegfried, John Amuasi, et al.. (2025). Improving the clinical trial environment and infrastructure: moving from global resolution to action. The Lancet Global Health. 13(4). e608–e610. 1 indexed citations

Ndembi, Nicaise, Morẹ́nikẹ́ Oluwátóyìn Foláyan, Nebiyu Dereje, et al.. (2024). Strengthening and expanding capacities in clinical trials: advancing pandemic prevention, preparedness and response in Africa. Nature Communications. 15(1). 8662–8662. 5 indexed citations

Makanga, Michael, et al.. (2024). Impact with equity: EDCTP and equitable research partnerships. The Lancet Global Health. 12(4). e552–e554.

Jarvis, Joseph N, Roger Chou, Thomas S. Harrison, et al.. (2023). Translating evidence into global impact: lessons for HIV research and policy development from the AMBITION trial. The Lancet Global Health. 11(11). e1688–e1690.

Hwenda, Lenias, et al.. (2022). The African Medicines Agency: the key to unlocking clinical research in Africa. The Lancet Global Health. 10(8). e1088–e1089. 19 indexed citations

Cobelens, Frank, et al.. (2022). Accelerating research and development of new vaccines against tuberculosis: a global roadmap. The Lancet Infectious Diseases. 22(4). e108–e120. 44 indexed citations

Kupfer, Linda, et al.. (2022). Funders' Perspectives on Supporting Implementation Research in Low- and Middle-Income Countries. Global Health Science and Practice. 10(2). e2100497–e2100497. 3 indexed citations

Nyirenda, Thomas, Moses J. Bockarie, Shingai Machingaidze, et al.. (2021). Strengthening capacity for clinical research in sub-Saharan Africa: partnerships and networks. International Journal of Infectious Diseases. 110. 54–61. 23 indexed citations

Rusakaniko, Simbarashe, Michael Makanga, Martin O. C. Ota, et al.. (2019). Strengthening national health research systems in the WHO African Region – progress towards universal health coverage. Globalization and Health. 15(1). 50–50. 25 indexed citations

10.

Breugelmans, J. Gabrielle, et al.. (2018). Scientific impact increases when researchers publish in open access and international collaboration: A bibliometric analysis on poverty-related disease papers. PLoS ONE. 13(9). e0203156–e0203156. 50 indexed citations

11.

Makanga, Michael. (2017). European & Developing Countries Clinical Trials Partnership. Impact. 2017(2). 12–13. 2 indexed citations

12.

Makanga, Michael, et al.. (2017). DEFEATING POVERTY-RELATED AND NEGLECTED DISEASES IN AFRICA: HARNESSING RESEARCH FOR EVIDENCE-INFORMED POLICIES. BMJ Global Health. 2(Suppl 2). A2–A2. 1 indexed citations

13.

Breugelmans, J. Gabrielle, et al.. (2015). Bibliometric Assessment of European and Sub-Saharan African Research Output on Poverty-Related and Neglected Infectious Diseases from 2003 to 2011. PLoS neglected tropical diseases. 9(8). e0003997–e0003997. 23 indexed citations

14.

Djimdé, Abdoulaye, Michael Makanga, Kelli Kuhen, & Kamal Hamed. (2015). The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine. Expert Review of Anti-infective Therapy. 13(8). 1031–1045. 13 indexed citations

15.

Makanga, Michael. (2014). A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission. Malaria Journal. 13(1). 291–291. 31 indexed citations

16.

Zumla, Alimuddin, Michael Makanga, Thomas Nyirenda, et al.. (2014). Genesis of EDCTP2. The Lancet Infectious Diseases. 15(1). 11–13. 11 indexed citations

17.

Makanga, Michael, Quique Bassat, Catherine O. Falade, et al.. (2011). Efficacy and Safety of Artemether-Lumefantrine in the Treatment of Acute, Uncomplicated Plasmodium falciparum Malaria: A Pooled Analysis. American Journal of Tropical Medicine and Hygiene. 85(5). 793–804. 46 indexed citations

18.

Makanga, Michael, Patrick G. Bray, Paul Horrocks, & Stephen A. Ward. (2005). Towards a proteomic definition of CoArtem action in Plasmodium falciparum malaria. PROTEOMICS. 5(7). 1849–1858. 37 indexed citations

19.

Falade, Catherine O., et al.. (2005). Efficacy and safety of artemether–lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 99(6). 459–467. 123 indexed citations

20.

Attaran, Amir, Karen I. Barnes, C. F. Curtis, et al.. (2004). WHO, the Global Fund, and medical malpractice in malaria treatment. The Lancet. 363(9404). 237–240. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact